Heart drug dilemma: when high potassium forces doctors to change lifesaving medications
NCT ID NCT04510792
Summary
This study aimed to understand how often high potassium levels (hyperkalemia) in hospitalized patients lead doctors to reduce or stop important heart medications called RAAS inhibitors. Researchers planned to observe adult patients in the hospital or emergency department who were taking these drugs and had a high potassium reading. The goal was to gather information to help guide future treatment decisions, but the study was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERKALEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital
Portsmouth, Hampshire, PO6 3LY, United Kingdom
Conditions
Explore the condition pages connected to this study.